AMWC Latin America 2025: EG Bio Continues Market Development Across Latin America

From October 16 to 18, 2025, EG Bio participated in AMWC Latin America 2025 in Medellín together with Genèse Labs France, continuing its structured expansion across Latin American markets.

AMWC Latin America typically welcomes 3,000+ medical professionals, 200+ exhibitors, and participants from across Central and South America, making it one of the region’s most important aesthetic medicine congresses.

At the congress, EG Bio and Genèse Labs France showcased their latest injectable and regenerative innovations while holding in-depth discussions with regional distributors on country-specific strategies, regulatory frameworks, and long-term cooperation.

About EG Bio

EG Bio Co., Ltd. is a global B2B supplier and distribution partner specializing in professional aesthetic products. The company works with selected international brands and manufacturers to support structured global distribution, market development, and long-term partnerships across multiple regions.

EG Bio focuses on exclusive distribution models, portfolio expansion, and international market access, providing distributors and professional partners with reliable supply, clear positioning, and sustainable growth opportunities.

About Genèse Labs France

Genèse Labs France is a France-based company focused on the development and management of aesthetic and dermocosmetic product portfolios for professional markets. The company works with selected manufacturing and distribution partners to support structured international expansion, emphasizing product quality, regulatory alignment, and long-term brand development.

Genèse Labs France positions its products for global markets through strategic partnerships, ensuring clear brand ownership, consistent positioning, and sustainable growth across multiple regions.